Measurement Tools and Utility of Hair Analysis for Screening Adherence to Antihypertensive Medication

Jyoti R. Sharma; Phiwayinkosi V. Dludla; Girish Dwivedi; Rabia Johnson

doi:10.5334/gh.1191

Measurement Tools and Utility of Hair Analysis for Screening Adherence to Antihypertensive Medication

Global Heart

Volume 18 (2023): Issue 1

By: Jyoti R. Sharma , Phiwayinkosi V. Dludla , Girish Dwivedi and Rabia Johnson

Open Access

|Mar 2023

Abstract

Poor adherence to the prescribed antihypertensive therapy is an understated public health problem and is one of the main causes of the high prevalence of uncontrolled hypertension in sub-Saharan Africa. Medication adherence is vital for the effectiveness of antihypertensive treatment and is key to ameliorating the clinical outcomes in hypertensive patients. However, it has often been ignored because the current methods used to assess medication adherence are not reliable, limiting their utilization in clinical practice. Therefore, the identification of the most accurate and clinically feasible method for measuring medication adherence is critical for tailoring effective strategies to improve medication adherence and consequently achieve blood pressure goals. This review not only explores various available methods for estimating medication adherence but also proposes therapeutic drug monitoring in hair for the measurement of medication adherence to the antihypertensive medication period.

References

Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis. PLOS One. 2014; 9(8): e104300. DOI: 10.1371/journal.pone.0104300
Open DOI Search in Google Scholar Back to article
World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
Search in Google Scholar Back to article
Mungal-Singh V. Lifestyle changes for hypertension: SA Hypertension Society Supplement. South African Family Practice. 2012; 54(2): S12–S16. DOI: 10.1080/20786204.2012.10874203
Open DOI Search in Google Scholar Back to article
Kamran A, Ahari SS, Biria M, Malpour A, Heydari H. Determinants of patient’s adherence to hypertension medications: Application of health belief model among rural patients. Annals of Medical and Health Sciences Research. 2014; 4(6): 922–927. DOI: 10.4103/2141-9248.144914
Open DOI Search in Google Scholar Back to article
Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008; 51(6): 1403–1419. DOI: 10.1161/HYPERTENSIONAHA.108.189141
Open DOI Search in Google Scholar Back to article
Ambaw AD, Alemie GA, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012; 12(1): 1–6. DOI: 10.1186/1471-2458-12-282
Open DOI Search in Google Scholar Back to article
Kably B, Billaud EM, Boutouyrie P, Azizi M. Is there any hope for monitoring adherence in an efficient and feasible way for resistant hypertension diagnosis and follow-up? Current Hypertension Reports. 2020; 22(11): 1–7. DOI: 10.1007/s11906-020-01105-6
Open DOI Search in Google Scholar Back to article
van der Linden EL, Agyemang C, van den Born BJH. Hypertension control in sub-Saharan Africa: Clinical inertia is another elephant in the room. Journal of Clinical Hypertension (Greenwich). 2020; 22(6): 959–961. DOI: 10.1111/jch.13874
Open DOI Search in Google Scholar Back to article
Muhamedhussein MS, Nagri ZI, Manji KP. Prevalence, risk factors, awareness, and treatment and control of hypertension in Mafia Island, Tanzania. International Journal of Hypertension. 2016; 2016: 1281384. DOI: 10.1155/2016/1281384
Open DOI Search in Google Scholar Back to article
Nielsen JØ, Shrestha A, Neupane D, Kallestrup P. Non-adherence to anti-hypertensive medication in low- and middle-income countries: A systematic review and meta-analysis of 92443 subjects. Journal of Human Hypertension. 2017; 31(1): 14–21. DOI: 10.1038/jhh.2016.31
Open DOI Search in Google Scholar Back to article
Burnier M, Wuerzner G. Qualitative assessments of adherence. In: Burnier M (Ed.), Drug adherence in hypertension and cardiovascular protection. 2018; 11–19. Cham: Springer. DOI: 10.1007/978-3-319-76593-8_2
Open DOI Search in Google Scholar Back to article
Gwadry-Sridhar FH, Manias E, Lal L, Salas M, Hughes DA, Ratzki-Leewing A, et al. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: A systematic review by the ISPOR medication adherence and persistence special interest group. Value in Health. 2013; 16(5): 863–871. DOI: 10.1016/j.jval.2013.03.1631
Open DOI Search in Google Scholar Back to article
Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication adherence and blood pressure control: A scientific statement from the American Heart Association. Hypertension. 2022; 79(1): e1–e14. DOI: 10.1161/HYP.0000000000000203
Open DOI Search in Google Scholar Back to article
Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low- and-middle-income countries: A systematic scoping review. Heliyon. 2022; 8(6): e09716. DOI: 10.1016/j.heliyon.2022.e09716
Open DOI Search in Google Scholar Back to article
Martin LR, Williams SL, Haskard KB, DiMatteo MR. The challenge of patient adherence. Therapeutics and Clinical Risk Management. 2005; 1(3): 189–199.
Search in Google Scholar Back to article
Iuga AO, McGuire MJ. Adherence and health care costs. Risk Management and Healthcare Policy. 2014; 7: 35. DOI: 10.2147/RMHP.S19801
Open DOI Search in Google Scholar Back to article
Jankowska-Polańska B, Uchmanowicz B, Szymańska-Chabowska A. Assessment of adherence to medication for cardiovascular diseases: measurement tools. Cardiovascular Journal of Africa. 2019; 30(2): 113–119. DOI: 10.5830/CVJA-2018-050
Open DOI Search in Google Scholar Back to article
Bernard L, Peytavin G. Indinavir concentrations in hair from patients receiving highly active antiretroviral therapy. Lancet. 1998; 352(9142): 1757–1758. DOI: 10.1016/S0140-6736(05)79831-7
Open DOI Search in Google Scholar Back to article
Bernard L, Vuagnat A, Peytavin G, Hallouin M-C, Bouhour D, Nguyen TH, et al. Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy. Annals of Internal Medicine. 2002; 137(8): 656–659. DOI: 10.7326/0003-4819-137-8-200210150-00009
Open DOI Search in Google Scholar Back to article
Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, et al. Protease inhibitor levels in hair samples strongly predict virologic responses to HIV treatment. AIDS (London, England). 2009; 23(4): 471–478. DOI: 10.1097/QAD.0b013e328325a4a9
Open DOI Search in Google Scholar Back to article
Kintz P. Evidence of 2 populations of mephedrone abusers by hair testing. Application to 4 forensic expertises. Current Neuropharmacology. 2017; 15(5): 658–662. DOI: 10.2174/1570159X14666161026152107
Open DOI Search in Google Scholar Back to article
Robbins CR. Chemical composition of different hair types. In: Chemical and physical behavior of human hair. 2012; 105–176. Berlin; Springer-Verlag. DOI: 10.1007/978-3-642-25611-0_2
Open DOI Search in Google Scholar Back to article
Gandhi M, Devi S, Bacchetti P, Chandy S, Heylen E, Phung N, et al. Measuring adherence to antiretroviral therapy via hair concentrations in India. Journal of Acquired Immune Deficiency Syndromes (1999). 2019; 81(2): 202–206. DOI: 10.1097/QAI.0000000000001993
Open DOI Search in Google Scholar Back to article
Taus F, Gottardo R, Ballotari M, Utzeri C, Tagliaro F. Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy. Drug Testing Analysis. 2022; 14(10): 1773–1778. DOI: 10.1002/dta.3346
Open DOI Search in Google Scholar Back to article
Lam WY, Fresco P. Medication adherence measures: An overview. BioMed Research International. 2015; 217047. DOI: 10.1155/2015/217047
Open DOI Search in Google Scholar Back to article
Meddings J, Kerr EA, Heisler M, Hofer TP. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: Still no better than a coin toss. BMC Health Services Research. 2012; 12(1): 1–11. DOI: 10.1186/1472-6963-12-270
Open DOI Search in Google Scholar Back to article
Durand H, Casey M, Glynn LG, Hayes P, Murphy AW, Molloy GJ. A qualitative comparison of high and low adherers with apparent treatment-resistant hypertension. Psychology, Health & Medicine. 2020; 25(1): 64–77. DOI: 10.1080/13548506.2019.1619788
Open DOI Search in Google Scholar Back to article
Atinga RA, Yarney L, Gavu NM. Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: A qualitative investigation. PLOS One. 2018; 13(3): e0193995. DOI: 10.1371/journal.pone.0193995
Open DOI Search in Google Scholar Back to article
Cremers AL, Alege A, Nelissen HE, Okwor TJ, Osibogun A, Gerrets R, et al. Patients’ and healthcare providers’ perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: A mixed methods study. Journal of Hypertension. 2019; 37(2): 389–397. DOI: 10.1097/HJH.0000000000001877
Open DOI Search in Google Scholar Back to article
Najjuma JN, Brennaman L, Nabirye RC, Ssedyabane F, Maling S, Bajunirwe F, et al. Adherence to antihypertensive medication: An interview analysis of southwest Ugandan patients’ perspectives. Annals of Global Health. 2020; 86(1): 58. DOI: 10.5334/aogh.2904
Open DOI Search in Google Scholar Back to article
Adebolu FA, Naidoo M. Blood pressure control amongst patients living with hypertension presenting to an urban district hospital outpatient clinic in Kwazulu-Natal. African Journal of Primary Health Care & Family Medicine. 2014; 6(1): E1–6. DOI: 10.4102/phcfm.v6i1.572
Open DOI Search in Google Scholar Back to article
Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Annals of Pharmacotherapy. 2004; 38(2): 303–312. DOI: 10.1345/aph.1D252
Open DOI Search in Google Scholar Back to article
Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P. Physicians’ ability to predict patients’ adherence to antihypertensive medication in primary care. Hypertension Research. 2008; 31(9): 1765–1771. DOI: 10.1291/hypres.31.1765
Open DOI Search in Google Scholar Back to article
Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013; 62(2): 218–225. DOI: 10.1161/HYPERTENSIONAHA.113.00687
Open DOI Search in Google Scholar Back to article
Fodor GJ, Kotrec M, Bacskai K, Dorner T, Lietava J, Sonkodi S, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. Journal of Hypertension. 2005; 23(6): 1261–1266. DOI: 10.1097/01.hjh.0000170390.07321.ca
Open DOI Search in Google Scholar Back to article
Pérez-Escamilla B, Franco-Trigo L, Moullin JC, Martínez-Martínez F, García-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Preference and Adherence. 2015; 9: 569. DOI: 10.2147/PPA.S76139
Open DOI Search in Google Scholar Back to article
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986; 67–74. DOI: 10.1097/00005650-198601000-00007
Open DOI Search in Google Scholar Back to article
Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Progress in Cardiovascular Nursing. 2000; 15(3): 90–96. DOI: 10.1111/j.1751-7117.2000.tb00211.x
Open DOI Search in Google Scholar Back to article
Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. Journal of Clinical Epidemiology. 2006; 59(6): 650–651. DOI: 10.1016/j.jclinepi.2005.10.013
Open DOI Search in Google Scholar Back to article
Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, et al. Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure. Clinical Therapeutics. 2000; 22(7): 858–871. DOI: 10.1016/S0149-2918(00)80058-2
Open DOI Search in Google Scholar Back to article
Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Education and Counseling. 1999; 37(2): 113–124. DOI: 10.1016/S0738-3991(98)00107-4
Open DOI Search in Google Scholar Back to article
Culig J, Leppee M. From Morisky to Hill-Bone; self-reports scales for measuring adherence to medication. Collegium Antropologicum. 2014; 38(1): 55–62.
Search in Google Scholar Back to article
Hamilton GA. Measuring adherence in a hypertension clinical trial. European Journal of Cardiovascular Nursing. 2003; 2(3): 219–228. DOI: 10.1016/S1474-5151(03)00058-6
Open DOI Search in Google Scholar Back to article
Nashilongo M, Singu B, Kalemeera F, Mubita M, Naikaku E, Baker A, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: Findings and implications. Cardiovascular Drugs and Therapy. 2017; 31(5): 565–578. DOI: 10.1007/s10557-017-6756-8
Open DOI Search in Google Scholar Back to article
Sarkodie E, Afriyie DK, Hutton-Nyameaye A, Amponsah SK. Adherence to drug therapy among hypertensive patients attending two district hospitals in Ghana. African Health Sciences. 2020; 20(3): 1355–1367. DOI: 10.4314/ahs.v20i3.42
Open DOI Search in Google Scholar Back to article
Ayodapo A, Elegbede O, Omosanya O, Monsudi K. Patient education and medication adherence among hypertensives in a tertiary hospital, South Western Nigeria. Ethiopian Journal of Health Sciences. 2020; 30(2): 243–250. DOI: 10.4314/ejhs.v30i2.12
Open DOI Search in Google Scholar Back to article
Okunrinboye HI, Otakpor AN, Ilesanmi OS. Depression and medication-adherence in patients with hypertension attending a tertiary health facility in South-West Nigeria. Pan African Medical Journal. 2019; 33: 27. DOI: 10.11604/pamj.2019.33.27.12941
Open DOI Search in Google Scholar Back to article
Mekonnen HS, Gebrie MH, Eyasu KH, Gelagay AA. Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia. BMC Pharmacology and Toxicology. 2017; 18(1): 1–10. DOI: 10.1186/s40360-017-0134-9
Open DOI Search in Google Scholar Back to article
Mugwano I, Kaddumukasa M, Mugenyi L, Kayima J, Ddumba E, Sajatovic M, et al. Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: A cross sectional study. BMC Research Notes. 2016; 9(1): 1–8. DOI: 10.1186/s13104-015-1830-4
Open DOI Search in Google Scholar Back to article
de Terline DM, Kramoh KE, Diop IB, Nhavoto C, Balde DM, Ferreira B, et al. Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross-sectional study from 12 sub-Saharan countries. Archives of Cardiovascular Diseases. 2020; 113(6–7): 433–442. DOI: 10.1016/j.acvd.2019.11.009
Open DOI Search in Google Scholar Back to article
Korb-Savoldelli V, Gillaizeau F, Pouchot J, Lenain E, Postel-Vinay N, Plouin PF, et al. Validation of a French version of the 8-item Morisky Medication Adherence Scale in hypertensive adults. Journal of Clinical Hypertension. 2012; 14(7): 429–434. DOI: 10.1111/j.1751-7176.2012.00634.x
Open DOI Search in Google Scholar Back to article
Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine. 2017; 96(4): e5641. DOI: 10.1097/MD.0000000000005641
Open DOI Search in Google Scholar Back to article
Adeoye AM, Adebiyi AO, Adebayo OM, Owolabi MO. Medication adherence and 24-h blood pressure in apparently uncontrolled hypertensive Nigerian patients. Nigerian Postgraduate Medical Journal. 2019; 26(1): 18. DOI: 10.4103/npmj.npmj_147_18
Open DOI Search in Google Scholar Back to article
Okunrinboye HI, Otakpor AN, Ilesanmi OS. Depression and medication-adherence in patients with hypertension attending a tertiary health facility in south-west Nigeria. Pan African Medical Journal. 2019; 33: 27. DOI: 10.11604/pamj.2019.33.27.12941
Open DOI Search in Google Scholar Back to article
Oluwole EO, Osibogun O, Adegoke O, Adejimi AA, Adewole AM, Osibogun A. Medication adherence and patient satisfaction among hypertensive patients attending outpatient clinic in Lagos University Teaching Hospital, Nigeria. Nigerian Postgraduate Medical Journal. 2019; 26(2): 129. DOI: 10.4103/npmj.npmj_48_19
Open DOI Search in Google Scholar Back to article
Adisa R, Ilesanmi OA, Fakeye TO. Treatment adherence and blood pressure outcome among hypertensive out-patients in two tertiary hospitals in Sokoto, Northwestern Nigeria. BMC Cardiovascular Disorders. 2018; 18(1): 1–10. DOI: 10.1186/s12872-018-0934-x
Open DOI Search in Google Scholar Back to article
Olowe OA, Ross AJ. Knowledge, adherence and control among patients with hypertension attending a peri-urban primary health care clinic, KwaZulu-Natal. African Journal of Primary Health Care & Family Medicine. 2017; 9(1): e1–e7. DOI: 10.4102/phcfm.v9i1.1456
Open DOI Search in Google Scholar Back to article
Lambert EV, Steyn K, Stender S, Everage N, Fourie JM. Cross-cultural validation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale in a South African, primary healthcare setting. Ethnicity and Disease. 2006; 16(1): 286.
Search in Google Scholar Back to article
Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. Journal of Clinical Epidemiology. 2010; 63(3): 299–306. DOI: 10.1016/j.jclinepi.2009.06.011
Open DOI Search in Google Scholar Back to article
Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill-Bone Compliance to High Blood Pressure Therapy Scale for use in primary health care settings. European Journal of General Practice. 2009; 15(4): 207–211. DOI: 10.3109/13814780903452150
Open DOI Search in Google Scholar Back to article
Osterberg L, Blaschke T. Adherence to medication. New England Journal of Medicine. 2005; 353(5): 487–497. DOI: 10.1056/NEJMra050100
Open DOI Search in Google Scholar Back to article
Pandey A, Raza F, Velasco A, Brinker S, Ayers C, Das SR, et al. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. Journal of the American Society of Hypertension. 2015; 9(6): 420–426.e2. DOI: 10.1016/j.jash.2015.04.004
Open DOI Search in Google Scholar Back to article
Hamdidouche I, Jullien V, Boutouyrie P, Billaud E, Azizi M, Laurent S. Drug adherence in hypertension: From methodological issues to cardiovascular outcomes. Journal of Hypertension. 2017; 35(6): 1133–1144. DOI: 10.1097/HJH.0000000000001299
Open DOI Search in Google Scholar Back to article
Tan X, Patel I, Chang J. Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8). INNOVATIONS in Pharmacy. 2014; 5(3): 5. DOI: 10.24926/iip.v5i3.347
Open DOI Search in Google Scholar Back to article
de Oliveira-Filho AD, Morisky DE, Neves SJ, Costa FA, de Lyra DP Jr., The 8-item Morisky Medication Adherence Scale: Validation of a Brazilian-Portuguese version in hypertensive adults. Research in Social & Administrative Pharmacy. 2014; 10(3): 554–561. DOI: 10.1016/j.sapharm.2013.10.006
Open DOI Search in Google Scholar Back to article
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertens (Greenwich). 2008; 10(5): 348–354. DOI: 10.1111/j.1751-7176.2008.07572.x
Open DOI Search in Google Scholar Back to article
Krousel-Wood M, Muntner P, Jannu A, Desalvo K, Re RN. Reliability of a medication adherence measure in an outpatient setting. The American Journal of the Medical Sciences. 2005; 330(3): 128–133. DOI: 10.1097/00000441-200509000-00006
Open DOI Search in Google Scholar Back to article
Ben AJ, Neumann CR, Mengue SS. Teste de Morisky-Green e Brief Medication Questionnaire para avaliar adesão a medicamentos. Revista de Saúde Pública. 2012; 46: 279–289. DOI: 10.1590/S0034-89102012005000013
Open DOI Search in Google Scholar Back to article
Pan J, Hu B, Wu L, Wang H, Lei T, Liu Z. The translation, reliability and validity of the Chinese version of the Hill-Bone Compliance to High Blood Pressure Therapy Scale in adults with hypertension. Patient Preference and Adherence. 2020; 14: 1853. DOI: 10.2147/PPA.S268031
Open DOI Search in Google Scholar Back to article
Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale in a South African, primary healthcare setting. Ethnicity & Disease. 2006; 16(1): 286–291.
Search in Google Scholar Back to article
Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. Journal of Clinical Epidemiology. 2008; 61(3): 282–288. DOI: 10.1016/j.jclinepi.2007.04.007
Open DOI Search in Google Scholar Back to article
Gozum S, Hacihasanoglu R. Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients. European Journal of Cardiovascular Nursing. 2009; 8(2): 129–136. DOI: 10.1016/j.ejcnurse.2008.10.006
Open DOI Search in Google Scholar Back to article
Porter AK, Taylor SR, Yabut AH, Al-Achi A. Impact of a pill box clinic to improve systolic blood pressure in veterans with uncontrolled hypertension taking 3 or more antihypertensive medications. Journal of Managed Care & Specialty Pharmacy. 2014; 20(9): 905–911. DOI: 10.18553/jmcp.2014.20.9.905
Open DOI Search in Google Scholar Back to article
Lee JY, Greene PG, Douglas M, Grim C, Kirk KA, Kusek JW, et al. Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study. Controlled Clinical Trials. 1996; 17(4 Suppl): 34s–39s. DOI: 10.1016/S0197-2456(97)82680-3
Open DOI Search in Google Scholar Back to article
García Navarro M, Orozco Beltrán D, Gil Guillén V, Carratalá Munuera C, Terol Moltó C, Merino Sánchez J. Relationship between drug compliance and degree of control in patients with hypertension, diabetes or dyslipidemia. Medicina clínica (Barc). 2001; 116(Suppl 2): 141–146.
Search in Google Scholar Back to article
Tedla YG, Bautista LE. Drug side effect symptoms and adherence to antihypertensive medication. American Journal of Hypertension. 2016; 29(6): 772–779. DOI: 10.1093/ajh/hpv185
Open DOI Search in Google Scholar Back to article
Adeyemo A, Tayo BO, Luke A, Ogedegbe O, Durazo-Arvizu R, Cooper RS. The Nigerian anti-hypertensive adherence trial (NA-HAT): A community-based randomized trial. Journal of Hypertension. 2013; 31(1): 201. DOI: 10.1097/HJH.0b013e32835b0842
Open DOI Search in Google Scholar Back to article
Elzubier AG, Husain AA, Suleiman IA, Hamid ZA. Drug compliance among hypertensive patients in Kassala, eastern Sudan. Eastern Mediterranean Health Journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2000; 6(1): 100–105. DOI: 10.26719/2000.6.1.100
Open DOI Search in Google Scholar Back to article
Maro EE, Lwakatare J. Medication compliance among Tanzanian hypertensives. East African Medical Journal. 1997; 74(9): 539–542.
Search in Google Scholar Back to article
Perseguer-Torregrosa Z, Orozco-Beltrán D, Gil-Guillen VF, Pita-Fernandez S, Carratalá-Munuera C, Pallares-Carratalá V, et al. Magnitude of pharmacological nonadherence in hypertensive patients taking antihypertensive medication from a community pharmacy in Spain. Journal of Managed Care Pharmacy. 2014; 20(12): 1217–1225. DOI: 10.18553/jmcp.2014.20.12.1217
Open DOI Search in Google Scholar Back to article
van Onzenoort HA, Verberk WJ, Kessels AG, Kroon AA, Neef C, van der Kuy PH, et al. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. American Journal of Hypertension. 2010; 23(2): 149–154. DOI: 10.1038/ajh.2009.207
Open DOI Search in Google Scholar Back to article
Vrijens B, Urquhart J. Methods for measuring, enhancing, and accounting for medication adherence in clinical trials. Clinical Pharmacology & Therapeutics. 2014; 95(6): 617–626. DOI: 10.1038/clpt.2014.59
Open DOI Search in Google Scholar Back to article
Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in Mozambique: Urban/rural gap during epidemiological transition. Hypertension. 2009; 54(1): 77–83. DOI: 10.1161/HYPERTENSIONAHA.109.132423
Open DOI Search in Google Scholar Back to article
Burnier M, Schneider MP, Chioléro A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions. Journal of Hypertension. 2001; 19(2): 335–341. DOI: 10.1097/00004872-200102000-00022
Open DOI Search in Google Scholar Back to article
Richter LH, Jacobs CM, Mahfoud F, Kindermann I, Böhm M, Meyer MR. Development and application of a LC-HRMS/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence. Analytica chimica acta. 2019; 1070: 69–79. DOI: 10.1016/j.aca.2019.04.026
Open DOI Search in Google Scholar Back to article
Volpp KG, Troxel AB, Mehta SJ, Norton L, Zhu J, Lim R, et al. Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction: The HeartStrong randomized clinical trial. JAMA Internal Medicine. 2017; 177(8): 1093–1101. DOI: 10.1001/jamainternmed.2017.2449
Open DOI Search in Google Scholar Back to article
Wetzels GE, Nelemans PJ, Schouten JS, Dirksen CD, van der Weijden T, Stoffers HE, et al. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. American Journal of Hypertension. 2007; 20(2): 119–125. DOI: 10.1016/j.amjhyper.2006.07.018
Open DOI Search in Google Scholar Back to article
Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoring. Canadian Journal of Cardiology. 1997; 13(10): 914–920.
Search in Google Scholar Back to article
Polonia J, Salgueiro A, Silva J, Barbosa L. Importance of the directly observed treatment intake on the approach of patients with resistant hypertension. Journal of Hypertension. 2018; 36: E65. DOI: 10.1097/01.hjh.0000539142.48753.af
Open DOI Search in Google Scholar Back to article
Ruzicka M, Leenen FH, Ramsay T, Bugeja A, Edwards C, McCormick B, et al. Use of directly observed therapy to assess treatment adherence in patients with apparent treatment-resistant hypertension. JAMA Internal Medicine. 2019; 179(10): 1433–1434. DOI: 10.1001/jamainternmed.2019.1455
Open DOI Search in Google Scholar Back to article
Eskås PA, Heimark S, Eek Mariampillai J, Larstorp AC, Fadl Elmula FE, Høieggen A. Adherence to medication and drug monitoring in apparent treatment-resistant hypertension. Blood Press. 2016; 25(4): 199–205. DOI: 10.3109/08037051.2015.1121706
Open DOI Search in Google Scholar Back to article
Pio-Abreu A, Trani-Ferreira F, Silva GV, Bortolotto LA, Drager LF. Directly observed therapy for resistant/refractory hypertension diagnosis and blood pressure control. Heart. 2022; 108(24): 1952–1956. DOI: 10.1136/heartjnl-2022-320802
Open DOI Search in Google Scholar Back to article
Hameed M, Tebbit L, Jacques N, Thomas M, Dasgupta I. Non-adherence to antihypertensive medication is very common among resistant hypertensives: Results of a directly observed therapy clinic. Journal of Human Hypertension. 2016; 30(2): 83–89. DOI: 10.1038/jhh.2015.38
Open DOI Search in Google Scholar Back to article
Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertension Research. 2011; 34(1): 87–90. DOI: 10.1038/hr.2010.183
Open DOI Search in Google Scholar Back to article
Štrauch B, Petrák O, Zelinka T, Rosa J, Šomlóová Z, Indra T, et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. Journal of Hypertension. 2013; 31(12): 2455–2461. DOI: 10.1097/HJH.0b013e3283652c61
Open DOI Search in Google Scholar Back to article
Florczak E, Tokarczyk B, Warchoł-Celińska E, Szwench-Pietrasz E, Prejbisz A, Gosk M, et al. Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. Polskie Archiwum Medycyny Wewnętrznej. 2015; 125(1–2): 65–72. DOI: 10.20452/pamw.2648
Open DOI Search in Google Scholar Back to article
Tanna S, Ogwu J, Lawson G. Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future perspectives. Clinical Chemistry and Laboratory Medicine (CCLM). 2020; 58(5): 643–663. DOI: 10.1515/cclm-2019-0820
Open DOI Search in Google Scholar Back to article
Mallion JM, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, et al. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. Journal of Hypertension. 1996; 14(1): 137–144. DOI: 10.1097/00004872-199601000-00018
Open DOI Search in Google Scholar Back to article
Mehta SJ, Volpp KG, Troxel AB, Day SC, Lim R, Marcus N, et al. Electronic pill bottles or bidirectional text messaging to improve hypertension medication adherence (Way 2 Text): A randomized clinical trial. Journal of General Internal Medicine. 2019; 34(11): 2397–2404. DOI: 10.1007/s11606-019-05241-x
Open DOI Search in Google Scholar Back to article
Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. Journal of Hypertension. 2013; 31(4): 766–774. DOI: 10.1097/HJH.0b013e32835e2286
Open DOI Search in Google Scholar Back to article
Gupta P, Patel P, Štrauch B, Lai FY, Akbarov A, Gulsin GS, et al. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017; 70(5): 1042–1048. DOI: 10.1161/HYPERTENSIONAHA.117.09631
Open DOI Search in Google Scholar Back to article
Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics. 1999; 21(6): 1074–1090. DOI: 10.1016/S0149-2918(99)80026-5
Open DOI Search in Google Scholar Back to article
Van Onzenoort HA, Verberk WJ, Kessels AG, Kroon AA, Neef C, van der Kuy P-HM, et al. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. American Journal of Hypertension. 2010; 23(2): 149–154. DOI: 10.1038/ajh.2009.207
Open DOI Search in Google Scholar Back to article
Rudd P, Byyny RL, Zachary V, LoVerde ME, Mitchell WD, Titus C, et al. Pill count measures of compliance in a drug trial: Variability and suitability. American Journal of Hypertension. 1988; 1(3, Pt 1): 309–312. DOI: 10.1093/ajh/1.3.309
Open DOI Search in Google Scholar Back to article
Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989; 261(22): 3273–3277. DOI: 10.1001/jama.1989.03420220087032
Open DOI Search in Google Scholar Back to article
Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clinical Pharmacology & Therapeutics. 1989; 46(2): 163–168. DOI: 10.1038/clpt.1989.121
Open DOI Search in Google Scholar Back to article
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. 2014(11): CD000011. DOI: 10.1002/14651858.CD000011.pub4
Open DOI Search in Google Scholar Back to article
Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis. Drugs. 2013; 73(6): 545–562. DOI: 10.1007/s40265-013-0041-3
Open DOI Search in Google Scholar Back to article
Bramley TJ, Nightengale BS, Frech-Tamas F, Gerbino PP. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. Journal of Managed Care Pharmacy. 2006; 12(3): 239–245. DOI: 10.18553/jmcp.2006.12.3.239
Open DOI Search in Google Scholar Back to article
Mallion J-M, Baguet J-P, Siche J-P, Tremel F, De Gaudemaris R. Compliance, electronic monitoring and antihypertensive drugs. Journal of Hypertension Supplement: Official Journal of the International Society of Hypertension. 1998; 16(1): S75–79.
Search in Google Scholar Back to article
Bovet P, Burnier M, Madeleine G, Waeber B, Paccaud F. Monitoring one-year compliance to antihypertension medication in the Seychelles. Bulletin of the World Health Organization. 2002; 80(1): 33–39.
Search in Google Scholar Back to article
Ayoade A, Oladipo I. Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy. Blood Pressure. 2012; 21(3): 161–166. DOI: 10.3109/08037051.2012.679029
Open DOI Search in Google Scholar Back to article
Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: A review of systematic reviews. Frontiers in Pharmacology. 2013; 4: 91. DOI: 10.3389/fphar.2013.00091
Open DOI Search in Google Scholar Back to article
Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLOS medicine. 2018; 15(7): e1002595. DOI: 10.1371/journal.pmed.1002595
Open DOI Search in Google Scholar Back to article
Basu S, Garg S, Sharma N, Singh MM. Improving the assessment of medication adherence: Challenges and considerations with a focus on low-resource settings. Tzu-Chi Medical Journal. 2019; 31(2): 73. DOI: 10.4103/tcmj.tcmj_177_18
Open DOI Search in Google Scholar Back to article
Lawson G, Fish R. Directly observed administration of antihypertensive medication prior to ambulatory blood pressure monitoring—A useful tool for investigating “resistant hypertension.” Journal of Hypertension. 2021; 39: e358. DOI: 10.1097/01.hjh.0000748684.71720.64
Open DOI Search in Google Scholar Back to article
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75(6): 1334–1357. DOI: 10.1161/HYPERTENSIONAHA.120.15026
Open DOI Search in Google Scholar Back to article
Lane D, Lawson A, Burns A, Azizi M, Burnier M, Jones DJ, et al. Nonadherence in hypertension: How to develop and implement chemical adherence testing. Hypertension. 2022; 79(1): 12–23. DOI: 10.1161/HYPERTENSIONAHA.121.17596
Open DOI Search in Google Scholar Back to article
de Jager RL, van Maarseveen EM, Bots ML, Blankestijn PJ. Medication adherence in patients with apparent resistant hypertension: Fndings from the SYMPATHY trial. British Journal of Clinical Pharmacology. 2018; 84(1): 18–24. DOI: 10.1111/bcp.13402
Open DOI Search in Google Scholar Back to article
Avataneo V, De Nicolò A, Rabbia F, Perlo E, Burrello J, Berra E, et al. Therapeutic drug monitoring–guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. British Journal of Clinical Pharmacology. 2018; 84(11): 2535–2543. DOI: 10.1111/bcp.13706
Open DOI Search in Google Scholar Back to article
Peeters LE, Feyz L, Boersma E, Daemen J, van Gelder T, Koch BC, et al. Clinical applicability of monitoring antihypertensive drug levels in blood. Hypertension. 2020; 76(1): 80–86. DOI: 10.1161/HYPERTENSIONAHA.120.15038
Open DOI Search in Google Scholar Back to article
Pucci M, Martin U. Detecting non-adherence by urine analysis in patients with uncontrolled hypertension: Rates, reasons and reactions. Journal of Human Hypertension. 2017; 31(4): 253–257. DOI: 10.1038/jhh.2016.69
Open DOI Search in Google Scholar Back to article
Maurer HH. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Therapeutic Drug Monitoring. 2010; 32(3): 324–327. DOI: 10.1097/FTD.0b013e3181dca295
Open DOI Search in Google Scholar Back to article
Ojanperä I, Kolmonen M, Pelander A. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Analytical and Bioanalytical Chemistry. 2012; 403(5): 1203–1220. DOI: 10.1007/s00216-012-5726-z
Open DOI Search in Google Scholar Back to article
Kristoffersen L, Øiestad EL, Opdal MS, Krogh M, Lundanes E, Christophersen AS. Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhytmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry: Method development and robustness testing by experimental design. Journal of Chromatography B. 2007; 850(1–2): 147–160. DOI: 10.1016/j.jchromb.2006.11.030
Open DOI Search in Google Scholar Back to article
Maurer HH, Tenberken O, Kratzsch C, Weber AA, Peters FT. Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography–mass spectrometry with atmospheric pressure chemical ionization. Journal of Chromatography A. 2004; 1058(1–2): 169–181. DOI: 10.1016/S0021-9673(04)01308-1
Open DOI Search in Google Scholar Back to article
Azizi M, Ménard J, Peyrard S, Lièvre M, Marre M, Chatellier G. Assessment of patients’ and physicians’ compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study. Diabetes Care. 2006; 29(6): 1331–1336. DOI: 10.2337/dc06-0255
Open DOI Search in Google Scholar Back to article
Ritscher S, Hoyer M, Georges C, Wunder C, Wallemacq P, Persu A, et al. Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy. PLOS One. 2020; 15(8): e0237383. DOI: 10.1371/journal.pone.0237383
Open DOI Search in Google Scholar Back to article
Helfer AG, Michely JA, Weber AA, Meyer MR, Maurer HH. Orbitrap technology for comprehensive metabolite-based liquid chromatographic–high resolution-tandem mass spectrometric urine drug screening—Exemplified for cardiovascular drugs. Analytica chimica acta. 2015; 891: 221–233. DOI: 10.1016/j.aca.2015.08.018
Open DOI Search in Google Scholar Back to article
De Nicolò A, Avataneo V, Rabbia F, Sciandra M, Tosello F, Cusato J, et al. UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. Journal of Pharmaceutical and Biomedical Analysis. 2017; 142: 279–285. DOI: 10.1016/j.jpba.2017.05.018
Open DOI Search in Google Scholar Back to article
Avataneo V, Fanelli E, De Nicolò A, Rabbia F, Palermiti A, Pappaccogli M, et al. A non-invasive method for detection of antihypertensive drugs in biological fluids: The salivary therapeutic drug monitoring. Frontiers in Pharmacology. 2022; 12: 3244. DOI: 10.3389/fphar.2021.755184
Open DOI Search in Google Scholar Back to article
Lawson G, Cocks E, Tanna S. Bisoprolol, ramipril and simvastatin determination in dried blood spot samples using LC-HRMS for assessing medication adherence. Journal of Pharmaceutical and Biomedical Analysis. 2013; 81: 99–107. DOI: 10.1016/j.jpba.2013.04.002
Open DOI Search in Google Scholar Back to article
Tanna S, Bernieh D, Lawson G. LC-HRMS analysis of dried blood spot samples for assessing adherence to cardiovascular medications. Journal of Bioanalysis & Biomedicine. 2015; 7(1): 1–5. DOI: 10.4172/1948-593X.1000115
Open DOI Search in Google Scholar Back to article
Wilhelm AJ, den Burger JC, Swart EL. Therapeutic drug monitoring by dried blood spot: Progress to date and future directions. Clinical Pharmacokinetics. 2014; 53(11): 961–973. DOI: 10.1007/s40262-014-0177-7
Open DOI Search in Google Scholar Back to article
Edelbroek PM, van der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: Methods, assays, and pitfalls. Therapeutic Drug Monitoring. 2009; 31(3): 327–336. DOI: 10.1097/FTD.0b013e31819e91ce
Open DOI Search in Google Scholar Back to article
Sharma A, Jaiswal S, Shukla M, Lal J. Dried blood spots: Concepts, present status, and future perspectives in bioanalysis. Drug testing and Analysis. 2014; 6(5): 399–414. DOI: 10.1002/dta.1646
Open DOI Search in Google Scholar Back to article
Tanna S, Lawson G, Thomas B. Opportunities and challenges for analytical chemistry in the assessment of medication adherence. In: Analytical chemistry for assessing medication adherence. 2016; 23–49. Amsterdam: Elsevier. DOI: 10.1016/B978-0-12-805463-5.00002-X
Open DOI Search in Google Scholar Back to article
Adewuya OA, Ajayi EA, Adetiloye AO, Atiba AS, Dada SA, Areo OO. Serum uric acid predicts antihypertensive medication adherence in Nigeria: A hospital based study. West African Journal of Medicine. 2020; 37(3): 225–230.
Search in Google Scholar Back to article
Jones E, Lesosky M, Blockman M, Castel S, Decloedt E, Schwager S, et al. Therapeutic drug monitoring of amlodipine and the Z-FHL/HHL ratio: Adherence tools in patients referred for apparent treatment-resistant hypertension. South African Medical Journal. 2017; 107(10): 887–891. DOI: 10.7196/SAMJ.2017.v107i10.12268
Open DOI Search in Google Scholar Back to article
Gandhi M, Ameli N, Bacchetti P, Huang Y, Gange S, Anastos K, et al (Eds.). Concentrations of efavirenz in hair are strongly correlated with virologic response. 16th Conference on Retroviruses and Opportunistic Infections (CROI); 2009.
Search in Google Scholar Back to article
DeLauder SF, Kidwell DA. The incorporation of dyes into hair as a model for drug binding. Forensic Science International. 2000; 107(1–3): 93–104. DOI: 10.1016/S0379-0738(99)00153-X
Open DOI Search in Google Scholar Back to article
Koren G, Klein J, Forman R, Graham K. Hair analysis of cocaine: Differentiation between systemic exposure and external contamination. Journal of Clinical Pharmacology. 1992; 32(7): 671–675. DOI: 10.1002/j.1552-4604.1992.tb05780.x
Open DOI Search in Google Scholar Back to article
Metcalfe J, Bacchetti P, Gerona R, Esmail A, Dheda K, Gandhi M. Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR-and XDR-TB. ERJ Open Research. 2019; 5(2). DOI: 10.1183/23120541.00046-2019
Open DOI Search in Google Scholar Back to article
Gerona R, Wen A, Aguilar D, Shum J, Reckers A, Bacchetti P, et al. Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel. Journal of chromatography B, Analytical Technologies in the Biomedical and Life Sciences. 2019; 1125: 121729. DOI: 10.1016/j.jchromb.2019.121729
Open DOI Search in Google Scholar Back to article
Reckers A, Wen A, Aguilar D, Bacchetti P, Gandhi M, Metcalfe J, et al. Validated LC-MS/MS panel for quantifying 11 drug-resistant TB medications in small hair samples. JoVE (Journal of Visualized Experiments). 2020; 159: e60861. DOI: 10.3791/60861-v
Open DOI Search in Google Scholar Back to article
Kintz P, Cirimele V, Sachs H, Jeanneau T, Ludes B. Testing for anabolic steroids in hair from two bodybuilders. Forensic Science International. 1999; 101(3): 209–216. DOI: 10.1016/S0379-0738(99)00024-9
Open DOI Search in Google Scholar Back to article
Ferrari A, Licata M, Rustichelli C, Baraldi C, Vandelli D, Marchesi F, et al. Monitoring of adherence to headache treatments by means of hair analysis. European Journal of Clinical Pharmacology. 2017; 73(2): 197–203. DOI: 10.1007/s00228-016-2163-5
Open DOI Search in Google Scholar Back to article
Zhang Q, Qiao S, Yang X, Li X. Antiretroviral concentration in hair as a measure for antiretroviral medication adherence: A systematic review of global literature. AIDS and Behavior. 2020; 24(1): 311–330. DOI: 10.1007/s10461-019-02460-5
Open DOI Search in Google Scholar Back to article
Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, et al. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clinical Infectious Diseases. 2011; 52(10): 1267–1275. DOI: 10.1093/cid/cir131
Open DOI Search in Google Scholar Back to article
Gandhi M, Mwesigwa J, Aweeka F, Plenty A, Charlebois E, Ruel TD, et al. Hair and plasma data show that lopinavir, ritonavir and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding. Journal of Acquired Immune Deficiency Syndromes (1999). 2013; 63(5): 578. DOI: 10.1097/QAI.0b013e31829c48ad
Open DOI Search in Google Scholar Back to article
Van Zyl GU, Van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, et al. Low lopinavir plasma or hair concentrations explain second line protease inhibitor failures in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes (1999). 2011; 56(4): 333. DOI: 10.1097/QAI.0b013e31820dc0cc
Open DOI Search in Google Scholar Back to article
Huang Y, Gandhi M, Greenblatt RM, Gee W, Lin ET, Messenkoff N. Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. Rapid Communications in Mass Spectrometry: An International Journal Devoted to the Rapid Dissemination of Up-to-the-Minute Research in Mass Spectrometry. 2008; 22(21): 3401–3409. DOI: 10.1002/rcm.3750
Open DOI Search in Google Scholar Back to article
Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: A review. Drug Design, Development and Therapy. 2019; 13: 2777. DOI: 10.2147/DDDT.S214907
Open DOI Search in Google Scholar Back to article
Ichida M, Fujita C, Sumie R, Miyano R, Inoue H. Simultaneous determination of minoxidil and minoxidil sulfate by high-performance liquid chromatography with UV-detection and its applications. Medicine in Drug Discovery. 2020; 7: 100050. DOI: 10.1016/j.medidd.2020.100050
Open DOI Search in Google Scholar Back to article
Bautista LE, Stein JH, Morgan BJ, Stanton N, Young T, Nieto FJ. Association of blood and hair mercury with blood pressure and vascular reactivity. WMJ: Official Publication of the State Medical Society of Wisconsin. 2009; 108(5): 250.
Search in Google Scholar Back to article
Marcinek K, Suliburska J, Krejpcio Z, Bogdanski P. Evaluation of mineral status in hypertensive patients undergoing pharmacotherapy. Roczniki Państwowego Zakładu Higieny. 2015; 66(1).
Search in Google Scholar Back to article
Gheddar L, Raul JS, Kintz P. First identification of a diuretic, hydrochlorothiazide, in hair: Application to a doping case and interpretation of the results. Drug Testing and Analysis. 2019; 11(1): 157–161. DOI: 10.1002/dta.2445
Open DOI Search in Google Scholar Back to article
Kintz P, Dumestre-Toulet V, Jamey C, Cirimele V, Ludes B. Doping control for beta-adrenergic compounds through hair analysis. Journal of Forensic Sciences. 2000; 45(1): 170–174. DOI: 10.1520/JFS14654J
Open DOI Search in Google Scholar Back to article
Lo Faro AF, Tini A, Gottardi M, Pirani F, Sirignano A, Giorgetti R, et al. Development and validation of a fast ultra high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair. Drug Testing and Analysis. 2021; 13(8): 1552–1560. DOI: 10.1002/dta.3055
Open DOI Search in Google Scholar Back to article
Wille SM, Peters FT, Di Fazio V, Samyn N. Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods. Accreditation and Quality Assurance. 2011; 16(6): 279–292. DOI: 10.1007/s00769-011-0775-0
Open DOI Search in Google Scholar Back to article
Macquart de Terline D, Kane A, Kramoh KE, Ali Toure I, Mipinda JB, Diop IB, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries. PLOS One. 2019; 14(7): e0219266. DOI: 10.1371/journal.pone.0219266
Open DOI Search in Google Scholar Back to article
Hickey MD, Salmen CR, Tessler RA, Omollo D, Bacchetti P, Magerenge R, et al. Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya. Journal of Acquired Immune Deficiency Syndromes. 2014; 66(3): 311–315. DOI: 10.1097/QAI.0000000000000154
Open DOI Search in Google Scholar Back to article
Gandhi M, Yang Q, Bacchetti P, Huang Y. Short communication: A low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settings. AIDS Research and Human Retroviruses. 2014; 30(1): 25–28. DOI: 10.1089/aid.2013.0239
Open DOI Search in Google Scholar Back to article
Kohli-Lynch CN, Lewsey J, Boyd KA, French DD, Jordan N, Moran AE, Sattar N, Preiss D, Briggs AH. Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Circulation. 2022; 145(17): 1312–1323. DOI: 10.1161/CIRCULATIONAHA.121.057631
Open DOI Search in Google Scholar Back to article
van Schoonhoven AV, Van Asselt AD, Tomaszewski M, Patel P, Khunti K, Gupta P, et al. Cost-utility of an objective biochemical measure to improve adherence to antihypertensive treatment. Hypertension. 2018; 72(5): 1117–1124. DOI: 10.1161/HYPERTENSIONAHA.118.11227
Open DOI Search in Google Scholar Back to article
Musiał J, Powierska-Czarny J, Czarny J, Raczkowski M, Galant N, Buszewski B, et al. One-step extraction and determination of 513 psychoactive substances, drugs, and their metabolites from hair by LC-MS/MS. Archives of Toxicology. 2022; 96(11): 2927–2933. DOI: 10.1007/s00204-022-03343-w
Open DOI Search in Google Scholar Back to article
Usman M, Naseer A, Baig Y, Jamshaid T, Shahwar M, Khurshuid S. Forensic toxicological analysis of hair: A review. Egyptian Journal of Forensic Sciences. 2019; 9(1): 1–12. DOI: 10.1186/s41935-019-0119-5
Open DOI Search in Google Scholar Back to article
Wu Y, Yang J, Duan C, Chu L, Chen S, Qiao S, et al. Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography–electrospray ionization–tandem mass spectrometry. Journal of Chromatography B. 2018; 1083: 209–221. DOI: 10.1016/j.jchromb.2018.03.021
Open DOI Search in Google Scholar Back to article
Hassall D, Brealey N, Wright W, Hughes S, West A, Ravindranath R, et al. Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD. Pulmonary Pharmacology & Therapeutics. 2018; 51: 59–64. DOI: 10.1016/j.pupt.2018.07.001
Open DOI Search in Google Scholar Back to article
Yu H, Jang WJ, Jang JH, Park B, Seo YH, Jeong CH, et al. Role of hair pigmentation in drug incorporation into hair. Forensic Science International. 2017; 281: 171–175. DOI: 10.1016/j.forsciint.2017.11.004
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.5334/gh.1191 | Journal eISSN: 2211-8179

Journal RSS Feed

Language: English

Submitted on: Aug 12, 2022

Accepted on: Feb 16, 2023

Published on: Mar 22, 2023

Published by: Ubiquity Press

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

hypertension,

drug/treatment adherence,

compliance,

antihypertensive medication

© 2023 Jyoti R. Sharma, Phiwayinkosi V. Dludla, Girish Dwivedi, Rabia Johnson, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 18 (2023): Issue 1